ask="1.7500"
ask_size="1000"
average_daily_volume="721653"
bid="1.5000"
bid_size="500"
book_value="1.0670"
change="+0.0294"
change_from_200_day_moving_average="-0.3337"
change_from_50_day_moving_average="0.1538"
change_from_52_week_high="-4.0836"
change_From_52_week_low="1.6739"
change_in_percent="+1.7764%"
close="1.6844"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.0060"
ebitda="-16.58M"
eps_estimate_current_year="-2.9100"
eps_estimate_next_quarter="-0.0600"
eps_estimate_next_year="-1.3700"
ex_dividend_date="N/A"
float_shares="5773000"
high="1.7300"
high_52_weeks="5.7680"
last_trade_date="2/17/2017"
last_trade_price="1.6844"
last_trade_size="1300"
last_trade_time="3:35pm"
low="1.6500"
low_52_weeks="0.0105"
market_capitalization="19.69M"
moving_average_200_day="2.0181"
moving_average_50_day="1.5306"
name="PhaseRx
Inc."
notes="N/A"
one_year_target_price="10.0000"
open="1.6900"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-16.5349%"
percent_change_from_50_day_moving_average="+10.0498%"
percent_change_from_52_week_high="-70.7975%"
percent_change_from_52_week_low="+15941.9053%"
previous_close="1.6550"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.5511"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="11690000"
short_ratio="0.2100"
stock_exchange="NCM"
symbol="PZRX"
volume="20857"
weeks_range_52="0.0105 - 5.7680"
